로딩 중…
지수 로딩 중…
Belite Bio, Inc
BLTE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$146.12-1.50%
2026-06-18
Price Chart
Belite Bio, Inc+142.08%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $5.86B |
| Revenue | $0.00 |
| Net Income | $-78M |
| Total Assets | $781M |
| Net Assets | $770M |
| Value | |
| P/B | 7.60x |
| Profitability | |
| ROE | -10.07% |
| ROA | -9.94% |
| Financial Health | |
| Debt Ratio | 1.31% |
| Total Debt | $429000.00 |
| Cash | $353M |
| Current Ratio | 50.02x |
| Performance | |
| 1Y Return | 142.08% |
| 1M Return | 4.60% |
| From 52W High | -26.94% |
| 1Y MDD | -29.10% |
| Trading | |
| Volume | 252,581 shares |
| Trading Value | $37M |
| Per Share | |
| EPS | $-2.31 |
| BPS | $22.97 |